Depression in later life: A more somatic presentation?  by Hegeman, J.M. et al.
Research report
Depression in later life: A more somatic presentation?
J.M. Hegeman a,e,n, M.W.M. de Waal b, H.C. Comijs c, R.M. Kok d, R.C. van der Mast e
a Department of Psychiatry, St. Antoniusziekenhuis, Utrecht, The Netherlands
b Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands
c Department of Psychiatry, EMGO Institute of Health and Care Research, VU Medical Centre, Amsterdam, The Netherlands
d Department of Old Age Psychiatry, Parnassia, Den Haag, The Netherlands
e Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands
a r t i c l e i n f o
Article history:
Received 7 April 2014
Received in revised form
21 August 2014
Accepted 22 August 2014
Available online 30 August 2014
Keywords:
Depression
Age
Somatic disease burden
a b s t r a c t
Background: Depression later in life may have a more somatic presentation compared with depression
earlier in life due to chronic somatic disease and increasing age. This study examines the inﬂuence of the
presence of chronic somatic diseases and increasing age on symptom dimensions of late-life depression.
Methods: Baseline data of 429 depressed and non-depressed older persons (aged 60–93 years) in the
Netherlands Study of Depression in Old Age were used, including symptom dimension scores as assessed
with the mood, somatic and motivation subscales of the Inventory of Depressive Symptomatology-Self
Report (IDS-SR). Linear regression was performed to investigate the effect of chronic somatic diseases
and age on the IDS-SR subscale scores.
Results: In depressed older persons a higher somatic disease burden was associated with higher scores
on the mood subscale (B¼2.02, p¼0.001), whereas higher age was associated with lower scores on the
mood (B¼2.30, po0.001) and motivation (B¼1.01, p¼0.006) subscales. In depressed compared with
non-depressed persons, a higher somatic disease burden showed no different association with higher
scores on the somatic subscale (F(1,12)¼9.2; p¼0.003; partial η2¼0.022).
Limitations: Because the IDS-SR subscales are speciﬁc for old age, it was not feasible to include persons
aged o60 years to investigate differences between earlier and later life.
Conclusions: It seems that neither higher somatic disease burden nor higher age contributes to more
severe somatic symptoms in late-life depression. In older old persons aged Z70 years, late-life
depression may not be adequately recognized because they may show less mood and motivational
symptoms compared with younger old persons.
& 2014 Elsevier B.V. All rights reserved.
1. Introduction
Depression later in life may have a more somatic presentation
compared with depression earlier in life (Wilkowska-Chmielewska
et al., 2013), thereby complicating the recognition of depression
(Mitchell et al., 2010). For instance, a recent meta-analysis found
that depressed older persons showed more hypochondriasis and
somatic symptoms of depression, whereas feelings of guilt and
loss of sexual interest were more related to early-life depression
(Hegeman et al., 2012a).
There are several explanations for a possibly more somatic
presentation of depression in late-life. For example, the symptoms
of (more frequent) somatic diseases in older age may be mistaken
for somatic symptoms of depression. Also, several studies found an
association between late-life depression and somatic comorbidity,
whereas others found a weakening association between depres-
sion and somatic diseases with increasing age, despite an increase
in the prevalence of somatic diseases (Braam et al., 2005; Kessler
et al., 2010; Lyness et al., 2006; Scott et al., 2008). Alternatively,
with increasing age depression might be characterized by more
somatic symptoms due to various underlying age-related biologi-
cal pathways in late-life depression compared with depression
earlier in life (Alexopoulos et al., 2002; Belvederi et al., 2014;
Kapfhammer, 2006; Krishnan et al., 2002; McKinney and Sibille,
2013; Naismith et al., 2012).
Using the Inventory of Depressive Symptomatology-Self Report
(IDS-SR) among older people, we earlier identiﬁed a mood,
motivation and somatic subscale reﬂecting three homogeneous
symptom dimensions (Hegeman et al., 2012b). These IDS-SR
symptom dimensions appeared to be speciﬁc for old age, as only
two symptom dimensions including ‘mood/cognition’ and ‘anxi-
ety/arousal’ were found at a younger age (Wardenaar et al., 2010).
The present study aims to investigate the effects of both somatic
comorbidity and increasing age on the presentation of late-life
depression according to the mood, motivation and somatic subscales
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of the IDS-SR (Hegeman et al. 2012b; Rush et al., 1996). To unravel
the possible misattribution of symptoms of chronic somatic diseases
and aging to depression, we examined the effects of chronic diseases
and aging on IDS-SR symptom severity in depressed and non-
depressed older people. We hypothesized that, with a higher number
of chronic somatic diseases and higher age, there would be a more
prominent somatic presentation of late-life depression as reﬂected in
higher scores on the IDS-SR somatic subscale. However, we expected
that a higher number of chronic somatic diseases and higher age
would not affect the presentation of late-life depression with respect
to mood and motivation symptoms according to the corresponding
IDS-SR symptom subscales.
2. Methods
2.1. Study sample
Data were used from the baseline assessment of the Nether-
lands Study of Depression in Old Persons (NESDO), conducted
among people agedZ60 years. NESDO is a multi-site naturalistic
cohort study examining the determinants, long-time course and
consequences of depressive disorders at old age. The design of the
NESDO is described in detail elsewhere (Comijs et al., 2011). In
short, between 2007 and 2010 participants were enrolled from
mental healthcare and primary healthcare settings to create a
sample reﬂecting all different stages of depression. Excluded were
persons with a psychotic disorder, obsessive–compulsive disorder
or severe addiction disorder, and insufﬁcient command of the
Dutch language. Also excluded were persons with a Mini-Mental
State Examination score (MMSE) o18 or a primary diagnosis of
dementia.
The baseline NESDO sample consists of 378 depressed (diag-
nosis within the last 6 months according to DSM-IV criteria) and
132 non-depressed persons aged 60–93 years (total sample
n¼510). The present study included 303 persons diagnosed with
a depressive disorder according to the DSM-IV criteria within the
last month before baseline assessment, and 132 non-depressed
persons, all with complete data on the IDS-SR. Persons with
missing total scores on all three subscales were excluded. For this
reason, 3 persons from the 303 depressed group and 3 persons
from the 132 non-depressed group were excluded, leaving 300
depressed and 129 non-depressed persons (total¼429) for the
present analysis. The persons with missing scores on all three
subscales did not differ from the included persons with respect to
gender (p¼0.313) and number of years of education (p¼0.057).
Both depressed and non-depressed persons were included to
examine differences in the presentation of depressive symptoms
due to somatic diseases and higher age in their own right, and in
relation to depression.
The study protocol was approved by the ethical review boards
of all the participating centers and informed consent was signed
by all participants.
2.2. Measures
2.2.1. Socio-demographics
Demographic information was collected with standard ques-
tions concerning age, gender and years of education. Age was used
as a categorical variable with a cut-off age of 70 years, being close
to both the median and mean age of the whole sample. Thus, the
‘younger old’ are deﬁned as people agedo70 years and the ‘older
old’ as people agedZ70 years.
2.2.2. Depressive symptoms and neuropsychiatric characteristics
The presence of a depressive disorder (major depression,
dysthymia and minor depression) according to the DSM-IV criteria
within the last month before the baseline assessment was mea-
sured with the Composite International Diagnostic Interview
(CIDI; WHO version 2.1; lifetime version) (Wittchen et al., 1991).
The Dutch translation of the IDS-SR (Rush et al., 1996) was used to
compute total scores of the three old-age speciﬁc IDS-SR subscales
(Hegeman et al. 2012b). The IDS-SR items of the mood, somatic
and motivation subscales were scored on a four-point scale (range
0–3 points) (Fig. 1). These age-speciﬁc subscales of the IDS-SR can
be used in older persons with no or different stages of depression
and have shown adequate properties across different age and
gender groups in late-life (Hegeman et al. 2012b). Global cognitive
functioning was assessed with the MMSE (Folstein et al., 1975).
2.2.3. Clinical characteristics
A self-report questionnaire was used to assess the presence of
chronic somatic diseases as follows: participants were asked
whether they had chronic non-speciﬁc lung disease, cardiovascular
diseases, diabetes mellitus, stroke, intestinal disorders, arthritis or
arthrosis, cancer, thyroid gland diseases, or any other disease.
Obtaining information on the presence of chronic somatic diseases
using a self-report questionnaire has shown to be adequate com-
pared with obtaining information from the general practitioner
(Kriegsman et al., 1996). The total number of chronic somatic
diseases was obtained by counting the number of self-reported
chronic somatic diseases (count 0–8), excluding hypertension, and
dichotomized into 0 or 1, and 2 or more chronic somatic diseases.
The cut-off of 2 chronic somatic diseases is close to the mean
number of chronic somatic diseases (1.9) in the whole sample, and
distinguishes between no/lower somatic disease burden and a
higher somatic disease burden.
The current smoking status was derived from the Fagerstrom
test for Nicotine Dependence. Alcohol use was deﬁned as the
amount of glasses consumed per day and assessed with the
Mood subscale 
Item 5 Feeling sad
Item 6 Feeling irritable
Item 7 Feeling anxious or tense
Item 8 Reactivity of mood
Item 10 Quality of mood
Item 17 Future pessimism
Item 18 Suicidal thoughts
Item 27 Panic/phobic symptoms
Item 29 Interpersonal sensitivity
Somatic subscale
Item 1 Initial insomnia
Item 2 Middle insomnia
Item 3 Early morning awakening
Item 11/12 Appetite disturbance
Item 13/14 Weight disturbance
Item 22 Interest in sex
Item 25 Aches and pains
Item 26 Sympathetic arousal
Motivation subscale
Item 4 Sleeping too much
Item 16 Self criticism and blame
Item 19 Interest in people/activities
Item 20 Energy/fatiguability
Item 23 Psychomotor retardation
Mood subscale: 9 items, maximum score=27; Somatic 
subscale: 8 items, maximum score=24; Motivation 
subscale: 5 items, maximum score=15. 
Abbreviations: IDS-SR, Inventory of Depressive  
Symptomatology-Self Report
Fig. 1. Items of the IDS-SR subscales.
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Alcohol Use Disorders Identiﬁcation Test; the results were cate-
gorized into 0, 1–2, and 42 glasses a day (Babor et al., 1989).
2.3. Statistical analysis
Data were analyzed using SPSS version 20.0. First, differences in
demographic, and neuropsychiatric and clinical characteristics,
between depressed and non-depressed older persons were eval-
uated using a t-test for continuous variables, chi-square tests for
categorical variables, and non-parametric tests for not normally
distributed variables. All analyses were carried out two-sided with
a signiﬁcance level of po0.05.
We performed three-way independent analyses of covariance
(ANCOVA) to obtain adjusted mean scores for each IDS-SR subscale in
eight distinctive groups deﬁned by the presence of depression,
the number of chronic somatic diseases, and age, as follows:
depressed persons aged o70 years with 0 or 1 chronic somatic
diseases, depressed persons aged o70 years with Z2 chronic
somatic diseases, depressed persons aged Z70 years with 0 or
1 chronic somatic diseases and with Z2 chronic somatic diseases,
non-depressed persons aged o70 years with 0 or 1 chronic somatic
diseases, non-depressed persons aged o70 years with Z2 chronic
somatic diseases, non-depressed persons aged Z70 years with 0 or
1 chronic somatic diseases and with Z2 chronic somatic diseases.
The dependent variable was the score on the IDS-SR subscale and the
three independent variables were depression, chronic somatic dis-
eases, and age. Potential confounding variables including gender,
years of education, alcohol use, smoking status, and MMSE were
added as covariates. We did not adjust for overall depression severity
because age-related or chronic somatic disease-related differences in
the scores of the IDS-SR subscales are also part of the total severity
score. Controlling for the severity of depression therefore involves
circularity, which could result in overadjustment. A full factorial
design was used in which the signiﬁcance (po0.10) of the two-way
interaction terms of depression and chronic somatic diseases,
depression and age, and chronic somatic diseases and age, and a
three-way interaction term involving depression, chronic somatic
diseases and age, were examined in the whole sample. Eta squared
(η2 40.01small effect size, η2 40.06medium effect size, and
η2 40.14 large effect size) and F ratios were used as a measure of
effect size.
In case of signiﬁcant interaction, the sample was stratiﬁed and
multiple linear regression analyses were performed for each IDS-
SR subscale in order to examine the inﬂuence of chronic somatic
diseases and age, respectively, on the presentation of depressive
symptoms. Potentially confounding variables including gender,
years of education, alcohol use, smoking status, and MMSE were
added to the regression model.
3. Results
Table 1 presents the demographic, neuropsychiatric and clinical
characteristics of the depressed and non-depressed persons.
Depressed persons had fewer years of education, a lower median
MMSE score, a higher number of chronic somatic diseases, were
Table 1
Comparison of demographic, neuropsychiatric and clinical characteristics between depressed and non-depressed persons.
Sample (n¼429) Depressed (n¼300) Non-depressed (n¼129) p-Value
Demographic characteristics
Mean age in years (SD) 70.5 (7.3) 70.0 (7.3)
Age range in years 60–90 60–93
Age Z70, n (%) 146 (48.7) 56 (43.4)
Women, n (%) 193 (64.3) 79 (61.2)
Mean years of education (SD) 10.4 (3.5) 12.5 (3.5)
Neuropsychiatric characteristics
Depressive disorders in past month, n (%)
Minor depression 20 (6.7) –
Dysthymia 94 (31.3) –
Major depression 272 (90.7) –
IDS-SR, mean total score (SD) 32.2 (12.4) 7.8 (6.4) o0.001
Mood subscale, mean total score 9.8 (5.0) 1.2 (2.0) o0.001
Somatic subscale, mean total score 10.1 (4.2) 4.9 (3.1) o0.001
Motivation subscale, mean total score 5.4 (3.1) 0.7 (1.2) o0.001
MMSE, median score (IQR) 28.0 (2) 29.0 (2) o0.001
Clinical characteristics
Mean number of chronic somatic diseases (SD) 2.1 (1.5) 1.5 (1.1) o0.001
Number of chronic somatic diseases present, n (%) o0.001
0–1 116 (38.7) 74 (57.4)
Z2 184 (61.3) 55 (42.6)
Chronic somatic disease present, n (%)
Diabetes mellitus 36 (12.0) 18 (14.0) 0.576
Chronic non-speciﬁc lung disease 48 (16.0) 9 (7.0) 0.012
Thyroid disease 32 (10.7) 7 (5.4) 0.083
Cardiovascular diseases 66 (22.0) 27 (20.9) 0.805
Stroke 35 (11.7) 3 (2.3) 0.002
Arthritis or arthrosis 146 (48.7) 59 (45.7) 0.577
Oncological diseases 57 (19.0) 24 (18.6) 0.924
Intestinal disorders 71 (23.7) 11 (8.5) o0.001
Current smoker, n (%) 82 (27.5) 10 (7.8) o0.001
Alcohol use, glasses/day, n (%) o0.001
0 122 (40.9) 17 (13.3)
1–2 152 (51.0) 84 (65.6)
42 24 (8.1) 27 (21.1)
Abbreviations: SD, standard deviation; IQR, interquartile range; MMSE, Mini-Mental State Examination; IDS-SR, Inventory of Depressive Symptomatology-Self Report; Means
(standard deviations) and overall p-Values with independent t-tests for normally distributed continuous variables; medians (interquartile range) and overall p-values with
nonparametric Mann–Whitney tests for skewed distributed continuous variables; number of persons (percentages) and overall p-Values with x2 tests for categorical
variables.
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more often smokers and used less alcohol, compared with non-
depressed persons. Some of the depressed persons had more than
one depressive disorder within the last month before baseline
assessment. Fig. 2 presents the adjusted mean scores of the three
IDS-SR subscales for subgroups deﬁned by depression, the number
of chronic somatic diseases and age (see also Table S1 Supple-
mentary material).
A signiﬁcant interaction was found between depression and the
number of chronic somatic diseases for the mood subscale (F(1,12)¼
3.47; p¼0.063; partial η2 ¼0.008); this indicates that, in depressed
compared with non-depressed persons, a higher somatic disease
burden had a different association with scores on the IDS-SR mood
subscale. However, no signiﬁcant interaction was found between
depression and the number of chronic somatic diseases for the
somatic (F(1,12)¼1.49; p¼0.223; partial η2 ¼0.004) and motivation
(F(1,12)¼0.43; p¼0.512; partial η2 0.001) subscales. This indicates a
similar association in depressed and non-depressed persons between
chronic somatic diseases and symptom severity of the somatic
subscale (F(1,12)¼9.20; p¼0.003; partial η2 ¼0.022), with a small
effect size. The same applies to the association between somatic
Fig. 2. Adjusted mean scores of the three IDS-SR subscales for subgroups deﬁned by depression, age and the number of chronic somatic diseases. Whiskers represent 95%
conﬁdence intervals of sample mean.
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disease burden and symptom severity of the motivation subscale
(F(1,12)¼4.94; p¼0.027; partial η2 ¼0.012). Furthermore, a signiﬁcant
interaction was found for depression and age for the mood (F(1,12)¼
7.57; p¼0.006; partial η2 ¼0.018), somatic (F(1,12)¼5.42; p¼0.020;
partial η2 ¼0.013), and motivation (F(1,12)¼5.16; p¼0.024; partial η2
¼0.013) subscales demonstrating that, in depressed compared with
non-depressed persons, age had a different association with symptom
severity of all three subscales. The ANCOVAs for all three IDS-SR
subscales, including all interaction terms, are shown in the supple-
mentary material (Tables S1 and S2).
Because signiﬁcant interactions were found, the subsequent
analyses were stratiﬁed according to depression status (Table 2). In
Table 2, the B coefﬁcient for chronic somatic diseases reﬂects the
difference in mean subscale scores of persons with higher somatic
disease burden compared with persons with lower somatic dis-
ease burden. Similarly, the B coefﬁcient for age equals the
difference in mean subscale scores found in ‘older old’ persons
compared with ‘younger old’ persons. Table 2 shows that, with
respect to the mood subscale, depressed persons with higher
somatic disease burden presented more severe mood symptoms
compared with depressed persons with lower somatic disease
burden, whereas older old depressed persons showed less severe
mood symptoms compared with younger old depressed persons.
In non-depressed persons, the presence of chronic somatic dis-
eases and age were not associated with the severity of mood
symptoms. With respect to the somatic subscale, the presence of
chronic somatic diseases was associated with symptom severity of
the somatic subscale in depressed but not in non-depressed
persons. Age was not associated with symptom severity of the
somatic subscale in depressed persons. However, in non-
depressed persons, higher age was associated with higher somatic
symptom severity. According to the motivation subscale, higher
somatic disease burden was associated with more severe motiva-
tional symptoms in both depressed and in non-depressed persons.
At the same time, older old depressed persons showed less severe
symptoms on the motivation subscale compared with younger old
depressed persons, whereas age was not associated with the
severity of motivational symptoms in non-depressed persons.
4. Discussion
This study examined the inﬂuence of somatic comorbidity and
age on the presentation of late-life depression. Remarkably, our
results demonstrate a reverse effect of the presence of chronic
somatic diseases compared with the effect of higher age on the
presentation of late-life depression on all three subscales. That is,
for all three subscales late-life depression was characterized by
higher symptom severity when a higher burden of somatic
diseases was present, and by less symptom severity with higher
age. However, the association between age and symptom severity
of the somatic subscale did not reach signiﬁcance. Thus, late-life
depression was not only characterized by more somatic symptoms
but also by more severe mood and motivational symptoms in the
presence of higher somatic disease burden, whereas the expected
more prominent somatic presentation of late-life depression in the
older old compared with younger old depressed persons was
not found.
In the non-depressed group, no such association in the oppo-
site direction of chronic somatic diseases compared with age was
consistently found for the three subscales. Non-depressed persons
showed no clinically relevant symptom severity on the mood and
motivation subscale, whereas chronic somatic diseases and age
were positively associated with symptom severity of the somatic
subscale. This ﬁnding that non-depressed persons showed more
somatic symptoms with more somatic disease burden or higher
age might be interpreted as somatic symptoms that appear with
the occurrence of chronic somatic diseases and aging. However, as
no signiﬁcant difference was found between depressed and non-
depressed persons in symptom severity of the somatic subscale
related to the presence of chronic somatic diseases, the more
prominent somatic presentation of late-life depression found in
the presence of higher somatic disease burden might be the
consequence of misattribution of symptoms of chronic somatic
diseases to depression. This latter ﬁnding concurs with our
previous study showing a relatively low internal consistency of
the somatic subscale compared with the other subscales and that
internal consistency of the somatic subscale was decreased in the
age group 470 years; this indicates a less homogeneous content
of the somatic subscale due to overlap of somatic symptoms of
depression and chronic diseases (Hegeman et al. 2012b). Further-
more, the slightly higher symptom severity of the motivation
subscale, found in the presence of higher somatic disease burden
in depressed and non-depressed persons, might represent sick-
ness behavior, even though the effect on symptom severity on the
mood scale for non-depressed persons did not reach signiﬁcance.
Our results are partly in line with others investigating the
relation between somatic diseases, age and the phenomenology of
depression as measured with a single item level of the Inventory of
Depressive Symptomatology Clinician Rating (IDS-C30) in
depressed persons aged 18–72 years (Husain et al., 2005; Yates
et al., 2004). Although the age range of the studies of Husain et al.
(2005) and Yates et al. (2004) only partly reﬂected our age range
and did not include the older old, some results were consistent
with our study, i.e. in the presence of somatic comorbidity more
symptoms of the somatic subscale (e.g. sympathetic arousal, and
aches and pains) were found and, with increasing age, less
symptoms of the mood subscale (e.g. irritability and negative
cognitions) were found.
In our study, the lower score found on the motivation subscale
in the older old compared with the younger old depressed persons
is in contrast to the generally found increase of apathy in older
depressed persons (Groeneweg-Koolhoven et al., 2014). However,
besides the motivational symptoms resembling apathy, the moti-
vational subscale also includes the item ‘sleeping too much’ as
well as a depressive cognitive item. Therefore, it can be questioned
whether scores on the motivational subscale adequately represent
apathy severity. Furthermore, in an earlier meta-analysis on age-
related differences in the phenomenology of depression, it was
found that older depressed persons compared with younger
depressed persons showed less feelings of guilt (Hegeman et al.,
2012a), which is in line with our current ﬁnding. Alternatively,
perhaps the increase of apathy generally found in older depressed
Table 2
Multivariate regression of age and chronic diseases on scores of IDS-SR subscales in
depressed and non-depressed persons.
Predictors Depressed Non-depressed
B SE β p-Value B SE β p-Value
Severity of symptoms of mood subscale
Diseases 2.02 0.58 0.197 0.001 0.64 0.37 0.162 0.082
Age 2.30 0.56 0.231 o0.001 0.48 0.36 0.120 0.189
Severity of symptoms of somatic subscale
Diseases 1.61 0.49 0.185 0.001 1.01 0.54 0.164 0.065
Age 0.70 0.48 0.082 0.145 1.28 0.53 0.208 0.018
Severity of symptoms of motivation subscale
Diseases 0.85 0.38 0.101 0.025 0.44 0.22 0.180 0.047
Age 1.01 0.37 0.163 0.006 0.17 0.21 0.069 0.435
Adjusted for gender, years of education, MMSE, current smoker and alcohol use.
Abbreviations: IDS-SR, Inventory of Depressive Symptomatology-Self Report.
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persons is particularly associated with cognitive dysfunctioning
rather than with higher age.
As suggested previously, late-life depression often remains
unnoticed (Mitchell et al., 2010); this is an important issue that
may be further clariﬁed by our results. The present ﬁnding that the
older old compared with younger old depressed persons show less
symptoms on the IDS-SR mood and motivational subscale implies
that, particularly in older old persons aged Z70 years, late-life
depression may not be recognized properly. A possible explanation
for this is a cohort effect of the current older generation not being
accustomed to expressing psychological symptoms (Lyness et al.,
1995). Furthermore, inconsistent results are reported on the topic
of speciﬁc age-related pathophysiological pathways in late-life
depression, such as the inﬂammatory and vascular depression
hypothesis (Alexopoulos and Morimoto, 2011; Jellinger, 2013;
Taylor et al., 2013). Age-speciﬁc pathophysiological pathways
might explain differences in the phenomenology of depression at
old age. However, until now, this issue has rarely been examined
except for executive and cognitive dysfunction in relation to
(cerebral) vascular diseases and vascular risk factors. For example,
in an older old depressed population, thoughts of death, sleep and
appetite-related symptoms of depression were found to be related
to inﬂammatory factors, whereas motivation symptoms were
related to vascular and degenerative risk factors (Naarding et al.,
2005). Moreover, our result of fewer mood symptoms in older old
depressed persons is unlikely to be the consequence of a wrongly
diagnosed depression instead of apathy as a syndrome of its own,
as no increase was found in symptoms on the motivation subscale,
including items resembling apathy.
Diagnosing late-life depression may also be complicated by
incorrect attribution of somatic symptoms of somatic diseases to
depression. Suggested solutions are an inclusive or exclusive
approach that includes or excludes all somatic symptoms of
depression when diagnosing late-life depression (Cohen-Cole
and Stoudemire, 1987; Drayer et al., 2005; Zisook and Downs,
1998). These latter solutions are limited to somatic symptoms
only, whereas the present study shows that somatic diseases are
also related to more severe mood and motivational symptoms. In
contrast to the somatic and motivational subscale, a signiﬁcant
difference was found in the association between severity of mood
symptoms and a higher somatic disease burden in depressed
compared with non-depressed persons. Accordingly, the higher
symptom severity of the mood subscale found in depressed
persons with higher somatic diseases burden might reﬂect a
strengthening of the symptoms of the depression itself and not
only of mood symptoms that co-exist with somatic diseases.
Therefore, an exclusive approach speciﬁcally related to all somatic
symptoms seems to be an appropriate solution to examine the
severity of late-life depression. Indeed, it may be difﬁcult to
establish whether a symptom is a result of a physical illness,
sickness behavior, the aging process, or depression. Therefore, an
etiological or substitutive approach, excluding or replacing only
somatic symptoms speciﬁcally caused by a somatic disease,
respectively, does not seem practical (Clark et al., 1983; Endicott,
1984; Kathol et al., 1990; Koenig et al., 1997; Rapp and Vrana, 1989;
Robinson et al., 1984). Thus, our results imply that severity of
depression may be overestimated in the presence of somatic
comorbidity, but only with respect to the somatic and motivational
symptom domain.
This study has some limitations. The IDS-SR subscales used are
speciﬁc for old age and differ from the previous IDS-SR subscales
used in younger age (Wardenaar et al., 2010). Therefore, we could
not include persons aged o60 years in this study to compare
them with older adults regarding the associations of somatic
diseases and IDS-SR symptom dimensions. Similarly, we could
not investigate the effect of younger age compared with older age
on the presentation of depressive symptoms according to the
symptom dimensions of the IDS-SR. A major strength of this study
is the large study sample consisting of depressed and non-
depressed persons. Therefore, differences in the effects of chronic
somatic diseases and age on depressive symptomatology between
depressed and non-depressed could be examined to distinguish
between symptoms wrongly attributed to depression and symp-
toms of the depression itself. Moreover, in this study a depressive
disorder was diagnosed using the CIDI and not by applying a cut-
off score on a symptom severity scale. Therefore, incorrectly
diagnosed depression due to misattribution of somatic symptoms
of chronic somatic diseases to depression was less likely to occur.
Furthermore, the study sample reﬂects different stages of depres-
sion and healthcare settings, thereby increasing the generalizabil-
ity of the results.
In conclusion, it appears that neither higher somatic disease
burden nor higher age contributes to more severe somatic symp-
toms of late-life depression. Our results imply that severity of late-
life depression may be overestimated in the presence of somatic
comorbidity, but only with respect to the somatic and motivational
symptom domain due to misattribution of symptoms of somatic
diseases and sickness behavior. In fact, higher somatic disease
burden does contribute to higher severity of mood symptoms of
late-life depression. Finally, particularly in the older old aged Z70
years, late-life depression may not be recognized properly as this
group tends to show less mood and motivational symptoms.
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